Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2023-06-07 00:00:00 ET · period of report 2023-06-05 · accession 0001209191-23-035256 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-07 | 2023-06-05+ | PCRX | GAUGLER DARYL | COO | S - Sale | $38.52 | -3,052 | 23.6K | -11% | -$117.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-07 | S | D | 1,047 | $37.87 | 21,539 | D | — | — | (F2) Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2023-06-06 | S | D | 1,005 | $38.99 | 22,586 | D | — | — | (F2) Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. |
| 3 | Common | Common Stock | 2023-06-05 | S | D | 1,000 | $38.74 | 23,591 | D | — | — |